Kinard David S 4
4 · Elanco Animal Health Inc · Filed Mar 3, 2023
Insider Transaction Report
Form 4
Kinard David S
SEE REMARKS
Transactions
- Tax Payment
Common Stock
2023-03-02$11.01/sh−1,009$11,109→ 113,541 total - Tax Payment
Common Stock
2023-03-01$11.26/sh−2,482$27,947→ 92,860 total - Award
Common Stock
2023-03-01+22,270→ 115,130 total - Award
Employee Stock Option (right to buy)
2023-03-01+50,863→ 50,863 totalExercise: $11.26Exp: 2033-03-01→ Common Stock (50,863 underlying)
Footnotes (5)
- [F1]Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the Amended and Restated 2018 Elanco Stock Plan.
- [F2]Includes 699 shares acquired under Elanco Animal Health Inc.'s Employee Stock Purchase Plan between September 30, 2022 and December 30, 2022.
- [F3]Grant of restricted stock units pursuant to the Amended and Restated 2018 Elanco Stock Plan on March 1, 2023, one-third vesting on March 1, 2024, one-third vesting on March 1, 2025, and the remaining vesting on March 1, 2026.
- [F4]Balance reflects 580 fewer shares due to an error in the number of shares previously reported as forfeited in a prior Form 4.
- [F5]Grant of stock options vesting as follows: one-third vesting on March 1, 2024, one-third vesting on March 1, 2025, and the remaining vesting on March 1, 2026.